Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taylor Vinters was an international law firm and advisory business focused on the innovation economy, serving clients across technology, venture capital, private wealth, and life sciences. The firm was particularly known in the UK innovation ecosystem, with strong roots in Cambridge and additional presence in London, Singapore, and the US through Taylor Vinters Via. Rather than developing therapeutics or healthcare products, it provided legal and related advisory services to companies, investors, founders, and institutions, including those in life sciences and digital health. Taylor Vinters entered a strategic combination with Mishcon de Reya in 2021, operated under the MDR Taylor Vinters structure during the transition, and completed its merger into Mishcon de Reya effective January 1, 2023. As a result, Taylor Vinters no longer operates as an independent company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taylor Vinters.